CEL-SCI Corporation  

(Public, NYSEMKT:CVM)   Watch this stock  
Find more results for CVM
1.09
0.00 (0.00%)
Aug 21 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 1.06 - 1.10
52 week 0.53 - 2.19
Open 1.07
Vol / Avg. 0.00/338,229.00
Mkt cap 86.85M
P/E     -
Div/yield     -
EPS -0.44
Shares 79.68M
Beta 1.58
Inst. own 9%
Aug 8, 2014
Q3 2014 CEL-SCI Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin -15364.42% -5746.93%
Operating margin -43377.31% -12450.36%
EBITD margin - -12063.59%
Return on average assets - -68.17%
Return on average equity - -134.48%
Employees 43 -
CDP Score - -

Address

Suite 802, 8229 Boone Boulevard
VIENNA, VA 22182
United States - Map
+1-703-5069460 (Phone)
+1-703-5069471 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

CEL-SCI Corporation (CEL-SCI) is engaged in the business of Multikine cancer therapy; New cold fill manufacturing service to the pharmaceutical industry, and ligand epitope antigen presentation System (LEAPS) technology, with two products, hemagglutinin type 1 and neuraminidase type 1 (H1N1) swine flu treatment for H1N1 hospitalized patients and CEL-2000, a rheumatoid arthritis treatment vaccine.

Officers and directors

Maximilian de Clara President, Director
Age: 84
Bio & Compensation  - Reuters
Geert R. Kersten Esq. Chief Executive Officer, Treasurer, Director
Age: 55
Bio & Compensation  - Reuters
Patricia B. Prichep Senior Vice President - Operations, Corporate Secretary
Age: 63
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
John Cipriano Senior Vice President - Regulatory Affairs
Age: 72
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Daniel H. Zimmerman Ph.D. Senior Vice President - Research, Cellular Immunology
Age: 73
Bio & Compensation  - Reuters
Eyal Talor Ph.D. Chief Scientific Officer
Age: 58
Bio & Compensation  - Reuters
Alexander G. Esterhazy Independent Director
Age: 72
Bio & Compensation  - Reuters
C. Richard Kinsolving Ph.D. Independent Director
Age: 78
Bio & Compensation  - Reuters
Peter R. Young Ph.D. Independent Director
Age: 69
Bio & Compensation  - Reuters